Yuji Yamamoto

Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy

Shigeru Kinoshita, Noriko Koizumi, Morio Ueno et al. · New England Journal of Medicine · 2018 · 555 citations

Medicine, Ophthalmology, Surgery +17

E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition

Junji Matsui, Yuji Yamamoto, Yasuhiro Funahashi et al. · International Journal of Cancer · 2007 · 547 citations

Medicine, Oncology, Pharmacology +17

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage

Yuji Yamamoto, Junji Matsui, Tomohiro Matsushima et al. · Vascular Cell · 2014 · 500 citations · Full text

Medicine, Oncology, Pharmacology +16

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models

Kiyoshi Okamoto, Kotaro Kodama, Kazuma Takase et al. · Cancer Letters · 2013 · 286 citations · Full text

Medicine, Oncology, Pharmacology +17

Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models

Masahiro Matsuki, Taisuke Hoshi, Yuji Yamamoto et al. · Cancer Medicine · 2018 · 262 citations · Full text

Medicine, Oncology, Pharmacology +17